PRLD
Prelude Therapeutics Inc
4.00$
+1.3%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.1% | 92.5% | 98.8% | 96.7% | 92.7% | 84.8% | 77.4% | 74.8% | |
| 95.1% | 86.3% | 97.6% | 10.4% | 13.9% | 9.1% | 7.1% | 24.9% | |
| 95.1% | 86.3% | 97.6% | 95.5% | 91.5% | 83.9% | 76.1% | 73.0% | |
| 4.9% | 7.5% | 1.1% | 1.8% | 3.0% | – | – | – | |
| 238.3% | 325.9% | 5.1% | 6.3% | 11.4% | 14.6% | 25.1% | 51.4% | |
| 14.9% | 22.1% | 5.1% | 6.3% | 9.8% | 7.9% | 14.6% | 37.5% | |
| – | 1.2% | – | 0.6% | 0.8% | 0.5% | 1.5% | 1.9% | |
| 8.3% | 9.0% | 1.8% | 2.6% | 3.1% | 1.6% | 4.4% | 2.8% | |
| -138.3% | -225.9% | 94.9% | 93.7% | 88.6% | 85.4% | 74.9% | 48.6% | |
| -139.7% | -230.9% | -48.0% | -71.8% | -151.7% | -164.4% | -332.5% | -483.4% | |
| 9.6% | 148.1% | 19.5% | 15.6% | 21.5% | 21.7% | 43.2% | 54.5% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.